青少年抑郁症与后续躯体疾病及过早死亡的相关性
基于瑞典1982-1996年出生人群的队列研究(n=1 487 964),青少年期抑郁症与66/69种躯体诊断风险升高相关,尤其自伤(女性HR 14.4)、睡眠障碍(HR 8.1)、病毒性肝炎(HR 6.1)、全因死亡(HR 5.9)及故意自伤死亡(HR 14.6)。控制精神共病后多数关联减弱但持续存在。
要点
- 青少年抑郁症患者后续66/69种躯体疾病风险升高,女性自伤HR达14.4。
- 全因死亡HR 5.9,故意自伤死亡HR 14.6,控制精神共病后仍持续。
- 12年内绝对风险差从男性关节病-0.2%到女性损伤类23.9%。
核心结论
- 青少年期诊断为抑郁症的患者后续多种躯体疾病及死亡风险升高,控制其他精神障碍后仍存在。
研究设计与样本
- 基于瑞典国家登记数据的 population-based 队列研究,纳入1982-1996年出生个体1 487 964人,从5岁随访至2013年。
- 青少年抑郁症定义为5-19岁间住院或门诊至少1次抑郁症诊断。
主要发现
- 37 185人(2.5%;67.4%女性)在5-19岁有抑郁症就诊,首次诊断平均年龄男性16.7(SD 2.1)岁、女性16.7(SD 1.8)岁。
- 青少年抑郁症患者69种躯体诊断中66种相对风险升高。
- 女性自伤HR 14.4(95%CI 13.8-15.1),睡眠障碍HR 8.1(95%CI 7.6-8.7),病毒性肝炎HR 6.1(95%CI 5.4-6.8)。
- 全因死亡HR 5.9(95%CI 5.3-6.6),故意自伤死亡HR 14.6(95%CI 12.6-16.9)。
- 控制精神共病后多数关联减弱但持续存在。
关键数值与推荐
- 12年内特定疾病绝对风险差范围:男性关节病-0.2%(95%CI -1.0%至0.6%)至女性损伤类23.9%(95%CI 22.7%-25.0%)。
临床怎么用
- 评估青少年抑郁症时应考虑共病躯体疾病风险,尤其自伤、睡眠障碍、病毒性肝炎及死亡风险。
以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。
原文
IMPORTANCE: Early-onset depression has been linked to poor health outcomes. However, it is unclear the extent to which this disorder is associated with specific diseases and premature death and whether these associations remain after controlling for psychiatric comorbidity. OBJECTIVE: To quantify the association of youth depression with subsequent diagnoses of numerous somatic diseases and mortality. DESIGN, SETTING, AND PARTICIPANTS: A population-based cohort study was conducted using Swedish national registers containing data on all individuals born in Sweden between 1982 and 1996. A total of 1 487 964 participants were followed up from age 5 years through 2013 if no censoring occurred. Data analysis was performed from January 15, 2019, to August 10, 2020. EXPOSURES: Youth depression was defined as having received at least 1 diagnosis of depression from inpatient or outpatient care between ages 5 and 19 years. MAIN OUTCOMES AND MEASURES: This study examined 69 somatic conditions diagnosed after youth depression, as well as all-cause and cause-specific mortalities. Overall and sex-specific hazard ratios (HRs), together with 95% CIs, were estimated using Cox proportional hazards regression with attained age as underlying timescale and time-varying exposure, and adjusted for birth year and sex. All analyses were repeated controlling for psychiatric comorbidities. Absolute risk differences were calculated using standardization with Cox proportional hazards regression. RESULTS: Of 1 487 964 individuals included in the analysis, 51.2% were male. A total of 37 185 patients (2.5%; 67.4% female) had an inpatient or outpatient contact for depression between ages 5 and 19 years (mean [SD] age at first recorded diagnosis of depression, 16.7 [2.1] years for males and 16.7 [1.8] years for females). Age at the end of follow-up ranged between 17 and 31 years. Individuals with youth depression had higher relative risks for 66 of the 69 somatic diagnoses. Strong associations were observed for certain injuries, especially self-harm in females (HR, 14.4; 95% CI, 13.8-15.1), sleep disorders (HR, 8.1; 95% CI, 7.6-8.7), viral hepatitis (HR, 6.1; 95% CI, 5.4-6.8), all-cause mortality (HR, 5.9; 95% CI, 5.3-6.6), and cause-specific mortalities, especially death by intentional self-harm (HR, 14.6; 95% CI, 12.6-16.9). Most associations were attenuated but persisted after adjusting for psychiatric comorbidity. The absolute risk difference of a specific disease within 12 years from the first diagnosis of depression during youth ranged from -0.2% (95% CI, -1.0% to 0.6%) for arthropathies among males to 23.9% (95% CI, 22.7%-25.0%) for the broader category of injuries among females. CONCLUSIONS AND RELEVANCE: In this Swedish population cohort study, patients with depression diagnosed during their youth appeared to have increased risks for many somatic diseases as well as for mortality, even after controlling for other psychiatric disorders. These findings suggest that several medical conditions should be considered when investigating youth depression.
引用
- Leone M, Kuja-Halkola R, Leval A, et al. Association of Youth Depression With Subsequent Somatic Diseases and Premature Death. JAMA Psychiatry. 2021. PMID: 33295952. doi:10.1001/jamapsychiatry.2020.3786
供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。